Content

Home » Guidelines » Public consultation » Public consultation on the draft revised Guidelines on Monoclonal Antibody Production

Public consultation on the draft revised Guidelines on Monoclonal Antibody Production

The NHMRC is keen to ensure that the Australian community has the best opportunity to participate in developing NHMRC reports. This page lists the current opportunities.If you'd like to be advised via email when new issues become available, subscribe here: Subscription Service and tick the NHMRC Tracker box or Media Releases (and major announcements) box.

The Guidelines on Monoclonal Antibody Production, issued by the NHMRC in 2001, are currently under review and are now available for public consultation.

The production of monoclonal antibodies (MAbs) using animals involves procedures which have the potential to produce significant pain and distress.  These guidelines arose in response to a growing awareness that a method of MAb production exists which can replace the use of animals for one of the stages of MAb production.  This method replaces the in vivo propagation of selected cells to produce MAbs with an in vitro method – though it is recognised that the use of animals for MAb production will continue to be required during the initial, immunisation stage of production, in the induction of antibody-producing cells in vivo.  While comments on all parts of the guidelines are welcomed, in particular we are seeking comments, supported by evidence, on the need for in vivo propagation of selected cells used in the production of MAbs. 

You are invited to make a submission to the NHMRC about the draft revised Guidelines on Monoclonal Antibody Production:

» Download: Draft revised guidelines (PDF, 444kb)

How to make your submission

Please make your submission in writing, by email or on audiotape.  In your submission please note the relevant page number/s that contain the issues on which you are providing comment.  Please also provide complete references for any research articles you deem relevant. All comments will be considered by the NHMRC.   

All submissions must be accompanied by a cover page:

» Download: Cover page for submissions (Word, 211kb)

Please send your submission to:

Project Officer – Monoclonal Antibody Production
Research Ethics Section
NHMRC
GPO Box 1421
CANBERRA ACT 2601
Tel: (02) 6217 9070  Fax: (02) 6217 9175
Email: ahec.nhmrc@nhmrc.gov.au

Closing date

The closing date for submissions is Wednesday 26 March 2008.

For further information please contact the Project Officer (contact details above).

[top]

Help

To view PDF documents use the Adobe Acrobat Reader:

 

Get Adobe Acrobat Reader icon

 

Linked documents tagged with the PDF icon PDF icon are formatted as Adobe Acrobat PDF (Portable Document Format) files. If you wish to view the PDF files you will need to install the Adobe Acrobat Reader on your computer. The Adobe Acrobat Reader is available for free download from the Adobe web site.

Note: Attempting to open large PDF files within the browser window may lead to system problems. For more information see Troubleshooting and access of large pdf documents.

footer links